Identification of Risk Factors for Daptomycin-Associated Creatine Phosphokinase Elevation and Development of a Risk Prediction Model for Incidence Probability
Autor: | Junki Inoue, Koji Tanikawa, Masaki Uchida, Ryuji Higashita, Yuki Enoki, Keisuke Takada, Junichi Ishii, Fumio Nagumo, Kazuaki Taguchi, Sakura Koshioka, Naoki Hirose, Masaru Samura, Norifumi Kunika, Takenori Kurata, Kazuaki Matsumoto |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
biology business.industry Incidence (epidemiology) daptomycin fungi Elevation risk score Major Articles Infectious Diseases AcademicSubjects/MED00290 Oncology risk factor trough concentration Internal medicine biology.protein Cardiology Medicine creatine phosphokinase Creatine kinase Daptomycin business medicine.drug incidence prediction model |
Zdroj: | Open Forum Infectious Diseases |
ISSN: | 2328-8957 |
Popis: | Background In this study, we investigated the risk factors for daptomycin-associated creatine phosphokinase (CPK) elevation and established a risk score for CPK elevation. Methods Patients who received daptomycin at our hospital were classified into the non-elevated or elevated CPK group based on their peak CPK levels during daptomycin therapy. Univariable and multivariable analyses were performed, and a risk score and prediction model for the incidence probability of CPK elevation were calculated based on logistic regression analysis. Results The non-elevated and elevated CPK groups included 181 and 17 patients, respectively. Logistic regression analysis revealed that concomitant statin use (odds ratio [OR], 4.45 [95% confidence interval {CI}, 1.40–14.47]; risk score 4), concomitant antihistamine use (OR, 5.66 [95% CI, 1.58–20.75]; risk score 4), and trough concentration (Cmin) between 20 and Conclusions These results suggested that concomitant use of statins with antihistamines and Cmin ≥20 µg/mL were risk factors for daptomycin-associated CPK elevation. Our prediction model might aid in reducing the incidence of daptomycin-associated CPK elevation. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |